Glibenclamide for the Treatment of Acute CNS Injury

First introduced into clinical practice in 1969, glibenclamide (US adopted name, glyburide) is known best for its use in the treatment of diabetes mellitus type 2, where it is used to promote the release of insulin by blocking pancreatic KATP [sulfonylurea receptor 1 (Sur1)-Kir6.2] channels. During...

Cijeli opis

Bibliografski detalji

Glavni autori:	J. Marc Simard, Nicholas M. Caffes, Volodymyr Gerzanich, Jason K. Karimy, Adam Pampori, Cigdem Tosun, David B. Kurland
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2013-10-01
Serija:	Pharmaceuticals
Teme:	glibenclamide Sur1-Trpm4 channel cerebral ischemia traumatic brain injury spinal cord injury encephalopathy of prematurity metastatic brain tumor
Online pristup:	http://www.mdpi.com/1424-8247/6/10/1287
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!